The purpose of this study is to look at the effectiveness of Atezolizumab alone or in combination with other chemo regimens. You must be diagnosed with metastatic colorectal cancer with a DNA mismatch repair deficiency and BRAF gene mutation.
Contact phone
Tera Williams | 517.364.2910
Contact email
Principal investigator
Dr. Gordan Srkalovic, MD, PhD
Trial Category
Trial SubCategory
Metastatic Colorectal